Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (641-650 of 1,211) with videos related to

Pageof 122
Sort By:
JACC. Heart Failure|October 4, 2024
Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection FractionBrendon L Neuen, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|June 27, 2023
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?Toru Kondo, Pooja Dewan, Inder S Anand, et al.
Kidney International Reports|April 30, 2025
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKDBernard Chan, Amanda Varghese, Sunil V Badve, et al.
The New England Journal of Medicine|September 24, 2004
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarctionNagesh S Anavekar, John J V McMurray, Eric J Velazquez, et al.
European Heart Journal|November 13, 2008
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo studyAlessandra Meris, Maria Amigoni, Hajime Uno, et al.
European Journal of Heart Failure|October 4, 2011
Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskirenAmil M Shah, Sung Hee Shin, Madoka Takeuchi, et al.
Journal of the American Heart Association|December 24, 2024
Multiparametric Assessment of Right Ventricular Dysfunction in Heart Failure: An Analysis From PARAGON-HFHenri Lu, Riccardo M Inciardi, Martin Abanda, et al.
Journal of the American College of Cardiology|April 8, 2024
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart FailureSafia Chatur, Brendon L Neuen, Brian L Claggett, et al.
European Journal of Heart Failure|October 19, 2017
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trialStephen J Greene, Javed Butler, Gregg C Fonarow, et al.
European Journal of Heart Failure|July 28, 2009
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trialJohn J V McMurray, Inder S Anand, Rafael Diaz, et al.
Pageof 122

Showing results (641-650 of 1,211) with videos related to

Sort By:
Pageof 122
JACC. Heart Failure|October 4, 2024
Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection FractionBrendon L Neuen, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|June 27, 2023
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?Toru Kondo, Pooja Dewan, Inder S Anand, et al.
Kidney International Reports|April 30, 2025
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKDBernard Chan, Amanda Varghese, Sunil V Badve, et al.
The New England Journal of Medicine|September 24, 2004
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarctionNagesh S Anavekar, John J V McMurray, Eric J Velazquez, et al.
European Heart Journal|November 13, 2008
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo studyAlessandra Meris, Maria Amigoni, Hajime Uno, et al.
European Journal of Heart Failure|October 4, 2011
Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskirenAmil M Shah, Sung Hee Shin, Madoka Takeuchi, et al.
Journal of the American Heart Association|December 24, 2024
Multiparametric Assessment of Right Ventricular Dysfunction in Heart Failure: An Analysis From PARAGON-HFHenri Lu, Riccardo M Inciardi, Martin Abanda, et al.
Journal of the American College of Cardiology|April 8, 2024
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart FailureSafia Chatur, Brendon L Neuen, Brian L Claggett, et al.
European Journal of Heart Failure|October 19, 2017
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trialStephen J Greene, Javed Butler, Gregg C Fonarow, et al.
European Journal of Heart Failure|July 28, 2009
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trialJohn J V McMurray, Inder S Anand, Rafael Diaz, et al.
Pageof 122